Several studies reported that PGAM1 is overexpressed in various cancers, including hepatocellular carcinoma (30), lung cancer (31), breast cancer (32), prostate cancer (22) and renal clear cell carcinoma (33). This evidence concerns the gene PGAM1 and breast carcinoma.